Patents by Inventor Marie Catherine Vozenin

Marie Catherine Vozenin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY WITH FAP-TARGETED CD40 AGONISTS
    Publication number: 20230340154
    Abstract: The present invention relates to combination therapies employing FAP-targeted CD40 agonists, in particular bispecific antigen binding molecules comprising at least one antigen binding domain capable of specific binding to Fibroblast Activation Protein (FAP) and at least one antigen binding domain capable of specific binding to CD40, and radiotherapy.
    Type: Application
    Filed: May 16, 2023
    Publication date: October 26, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Sara Labiano Alminana, Pedro Romero, Genrich Tolstonog, Christine Trumpfheller, Pablo Umana, Marie Catherine Vozenin
  • EGFR INHIBITOR AND ANTIVIRAL AGENT FOR SIMULTANEOUS, SEPARATE OR SEQUENTIAL USE IN THE TREATMENT AND/OR PREVENTION AND/OR PALLIATION OF CANCER
    Publication number: 20130189248
    Abstract: The application relates to a combination of biologically active compounds comprising at least one antiviral agent and at least one EGFR antagonist, for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of malignant or pre-malignant neoplasms, preferably of solid malignant or pre-malignant neoplasms.
    Type: Application
    Filed: March 24, 2011
    Publication date: July 25, 2013
    Inventors: Eric Deutsch, Marie Catherine Vozenin, Jean Bourhis